168 related articles for article (PubMed ID: 21702940)
1. Cell subset prediction for blood genomic studies.
Bolen CR; Uduman M; Kleinstein SH
BMC Bioinformatics; 2011 Jun; 12():258. PubMed ID: 21702940
[TBL] [Abstract][Full Text] [Related]
2. The blood transcriptional signature of chronic hepatitis C virus is consistent with an ongoing interferon-mediated antiviral response.
Bolen CR; Robek MD; Brodsky L; Schulz V; Lim JK; Taylor MW; Kleinstein SH
J Interferon Cytokine Res; 2013 Jan; 33(1):15-23. PubMed ID: 23067362
[TBL] [Abstract][Full Text] [Related]
3. Molecular signatures of peripheral blood mononuclear cells during chronic interferon-α treatment: relationship with depression and fatigue.
Felger JC; Cole SW; Pace TW; Hu F; Woolwine BJ; Doho GH; Raison CL; Miller AH
Psychol Med; 2012 Aug; 42(8):1591-603. PubMed ID: 22152193
[TBL] [Abstract][Full Text] [Related]
4. Improved cell composition deconvolution method of bulk gene expression profiles to quantify subsets of immune cells.
Chiu YJ; Hsieh YH; Huang YH
BMC Med Genomics; 2019 Dec; 12(Suppl 8):169. PubMed ID: 31856824
[TBL] [Abstract][Full Text] [Related]
5. Multicohort Analysis Identifies Monocyte Gene Signatures to Accurately Monitor Subset-Specific Changes in Human Diseases.
Vallania F; Zisman L; Macaubas C; Hung SC; Rajasekaran N; Mason S; Graf J; Nakamura M; Mellins ED; Khatri P
Front Immunol; 2021; 12():659255. PubMed ID: 34054824
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations in host IL28B links to the detection of peripheral blood mononuclear cells-associated hepatitis C virus RNA in chronically infected patients.
Angulo J; Pino K; Pavez C; Biel F; Labbé P; Miquel JF; Soza A; López-Lastra M
J Viral Hepat; 2013 Apr; 20(4):263-72. PubMed ID: 23490371
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood mononuclear cells microRNA predicts treatment outcome of hepatitis C virus genotype 1 infection.
Hsi E; Huang CF; Dai CY; Juo SH; Chou WW; Huang JF; Yeh ML; Lin ZY; Chen SC; Wang LY; Chuang WL; Yu ML
Antiviral Res; 2014 May; 105():135-42. PubMed ID: 24637254
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of PBMC gene expression in hepatitis C virus genotype 1-infected patients during combined peginterferon/ribavirin therapy.
Lu MY; Huang CI; Hsieh MY; Hsieh TJ; Hsi E; Tsai PC; Tsai YS; Lin CC; Hsieh MH; Liang PC; Lin YH; Hou NJ; Yeh ML; Huang CF; Lin ZY; Chen SC; Huang JF; Chuang WL; Dai CY; Yu ML
Oncotarget; 2016 Sep; 7(38):61325-61335. PubMed ID: 27542257
[TBL] [Abstract][Full Text] [Related]
9. Identification of Suitable Reference Genes for Peripheral Blood Mononuclear Cell Subset Studies in Multiple Sclerosis.
Oturai DB; Søndergaard HB; Börnsen L; Sellebjerg F; Christensen JR
Scand J Immunol; 2016 Jan; 83(1):72-80. PubMed ID: 26395032
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling reveals similarities between the in vitro and in vivo responses of immune effector cells to IFN-alpha.
Zimmerer JM; Lesinski GB; Ruppert AS; Radmacher MD; Noble C; Kendra K; Walker MJ; Carson WE
Clin Cancer Res; 2008 Sep; 14(18):5900-6. PubMed ID: 18794103
[TBL] [Abstract][Full Text] [Related]
11. Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C.
Ji X; Cheung R; Cooper S; Li Q; Greenberg HB; He XS
Hepatology; 2003 Mar; 37(3):610-21. PubMed ID: 12601359
[TBL] [Abstract][Full Text] [Related]
12. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hepatitis C virus infection with direct-acting antivirals plus ribavirin eliminates viral RNA from peripheral blood mononuclear cells and reduces virologic relapse in diverse hepatic parenchymal changes.
Abd Alla MDA; Dawood RM; Rashed HAE; Farrag G; Ammar IAE; Mahmoud MMA; Salum GM; Altanbouly AMA; El Meguid MA; Awady MKE
Arch Virol; 2021 Apr; 166(4):1071-1081. PubMed ID: 33533976
[TBL] [Abstract][Full Text] [Related]
14. Presence of HCV RNA in peripheral blood mononuclear cells may predict patients response to interferon and ribavirin therapy.
Zaman N; Asad MJ; Raza A; Raja GK; Akhter S; Mahmood M; Mahmood RT
Ann Saudi Med; 2014; 34(5):401-6. PubMed ID: 25827697
[TBL] [Abstract][Full Text] [Related]
15. RNA-Seq analysis of peripheral blood mononuclear cells reveals unique transcriptional signatures associated with radiotherapy response of nasopharyngeal carcinoma and prognosis of head and neck cancer.
Liu G; Zeng X; Wu B; Zhao J; Pan Y
Cancer Biol Ther; 2020; 21(2):139-146. PubMed ID: 31698994
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of interferon alpha inducible genes in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus and healthy donors.
MacParland SA; Corkum CP; Burgess C; Karwowska S; Kroll W; Michalak TI
Int Immunopharmacol; 2015 Apr; 25(2):545-52. PubMed ID: 25765354
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling of peripheral-blood mononuclear cells from patients with chronic hepatitis C undergoing interferon therapy.
Tateno M; Honda M; Kawamura T; Honda H; Kaneko S
J Infect Dis; 2007 Jan; 195(2):255-67. PubMed ID: 17191171
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant-Associated Peripheral Blood mRNA Profiles and Kinetics Induced by the Adjuvanted Recombinant Protein Candidate Tuberculosis Vaccine M72/AS01 in Bacillus Calmette-Guérin-Vaccinated Adults.
van den Berg RA; De Mot L; Leroux-Roels G; Bechtold V; Clement F; Coccia M; Jongert E; Evans TG; Gillard P; van der Most RG
Front Immunol; 2018; 9():564. PubMed ID: 29632533
[TBL] [Abstract][Full Text] [Related]
19. Genetic profiles of transcriptomic clusters of childhood asthma determine specific severe subtype.
Yeh YL; Su MW; Chiang BL; Yang YH; Tsai CH; Lee YL
Clin Exp Allergy; 2018 Sep; 48(9):1164-1172. PubMed ID: 29758111
[TBL] [Abstract][Full Text] [Related]
20. Rapid virological response in peripheral blood mononuclear cells with an increase of hepatitis C virus-specific interferon-gamma production predisposes to sustained virological response in patients with chronic hepatitis C genotype 1 undergoing treatment with pegylated-interferon alpha 2a plus ribavirin.
Perrella A; Sbreglia C; Atripaldi L; Esposito C; D'Antonio A; Perrella O
Scand J Gastroenterol; 2010; 45(2):250-5. PubMed ID: 19968615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
